Posted Wed, Jun, 27,2012
Biomarkers in Cancer has formally joined the Committee on Publishing Ethics.
COPE provides guidelines that are applied in situations such as where plagiarism allegations are made against a paper. By becoming a COPE member there can be no doubt amongst authors of questionable papers that journals will apply commonly accepted industry-standard guidelines. In more difficult cases Editors in Chief and Associate Editors will have access to COPE's advisory group.
Membership of COPE reflects our commitment to providing Biomarkers in Cancer readers and authors with highly professional and well organised scholarly publishing and research.
To read more visit the Biomarkers in Cancer Aims and Scope page
Fri 17 May, 2013Ophthalmology and Eye Disease Now on PubMed
Fri 17 May, 2013RNAi Stratagems Against HIV-1
Thu 16 May, 2013Journal of Central Nervous System Disease on PubMed
I have had contact with Drug Target Insights several times, and every time I am impressed by the handling of the manuscript. The website is very, very user-friendly. It is easy to submit a manuscript. The entire process is easy and straightforward. The corresponding author is kept updated on the progress at every point. The editors of Libertas were helpful and prompt in responding to questions and issues related to the submission I am pleased ...
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.See Our Results
Copyright © 2013 Libertas Academica Ltd (except open access articles and accompanying metadata and supplementary files.)